Literature DB >> 17714833

Exploration of physicochemical properties and molecular modelling studies of 2-sulfonyl-phenyl-3-phenyl-indole analogs as cyclooxygenase-2 inhibitors.

Arun Kumar Gupta1, Revathi A Gupta, Love Kumar Soni, S G Kaskhedikar.   

Abstract

In the present work, modelling study has been performed to explore the physicochemical requirements of 2-sulfonyl-phenyl-3-phenyl-indole analogs as COX-2 enzyme inhibitors. The multivariant regression expressions were developed using sequential multiple linear regression (SEQ-MLR) technique, considering adjustable correlation coefficient (r(adj)(2)). The statistical quality of SEQ-MLR equations was evaluated considering parameters like correlation coefficient (r), standard error of estimation (SEE), and variance ratio (F) at explicit degree of freedom (df). Orthogonality of the descriptors in SEQ-MLR was established through variance inflation factor (VIF). Developed equations have been internally validated using leave-one-out technique and further validated with test set, considering predictive squared correlation coefficient (r(pred)(2)). The orientation of the most potent and selective COX-2 inhibitor of training set, 2-(4-phenyl sulfonamide)-3-phenyl-5-methylindole, in the COX-2 active site was explored by docking. The phenyl sulfonamide moiety positioned in secondary pocket of enzyme which consists of amino acid residues Phe(518), Gln(192), Arg(513), Leu(352), Ser(353) and Val(523) is responsible for the selectivity. The unsubstituted phenyl ring positions in a hydrophobic cavity are lined by Tyr(385), Trp(387), Tyr(348), Leu(384) and Met(522). Interestingly, the indole C-5 CH(3)-substituent is located in a hydrophobic region formed by Ile(345), Val(349), Ala(527), Leu(531) and Leu(534). The hydrophobic interactions of methyl group might be crucial for the potency of 2-sulfonyl-phenyl-3-phenyl-indole analogs. Study has revealed that atomic van der Waals volume and atomic masses explain COX-2 inhibitory activity of 2-sulfonyl-phenyl-3-phenyl-indole analogs significantly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17714833     DOI: 10.1016/j.ejmech.2007.06.022

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

1.  Lead compound design for TPR/COX dual inhibition.

Authors:  Abhay Krishna; Arpita Yadav
Journal:  J Mol Model       Date:  2012-05-16       Impact factor: 1.810

2.  Problems with molecular mechanics implementations on the example of 4-benzoyl-1-(4-methyl-imidazol-5-yl)-carbonylthiosemicarbazide.

Authors:  Agata Siwek; Katarzyna Swiderek; Stefan Jankowski
Journal:  J Mol Model       Date:  2011-05-28       Impact factor: 1.810

3.  Extended Multitarget Pharmacology of Anticancer Drugs.

Authors:  Da Shi; Feroz Khan; Ruben Abagyan
Journal:  J Chem Inf Model       Date:  2019-05-03       Impact factor: 4.956

4.  Diverse methyl sulfone-containing benzo[b]thiophene library via iodocyclization and palladium-catalyzed coupling.

Authors:  Chul-Hee Cho; Benjamin Neuenswander; Richard C Larock
Journal:  J Comb Chem       Date:  2010-03-08

5.  2-Carbaborane-3-phenyl-1H-indoles--synthesis via McMurry reaction and cyclooxygenase (COX) inhibition activity.

Authors:  Markus Laube; Wilma Neumann; Matthias Scholz; Peter Lönnecke; Brenda Crews; Lawrence J Marnett; Jens Pietzsch; Torsten Kniess; Evamarie Hey-Hawkins
Journal:  ChemMedChem       Date:  2013-01-09       Impact factor: 3.466

Review 6.  Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years.

Authors:  Zhiran Ju; Menglan Li; Junde Xu; Daniel C Howell; Zhiyun Li; Fen-Er Chen
Journal:  Acta Pharm Sin B       Date:  2022-01-11       Impact factor: 14.903

7.  Identification of Potential COX-2 Inhibitors for the Treatment of Inflammatory Diseases Using Molecular Modeling Approaches.

Authors:  Pedro H F Araújo; Ryan S Ramos; Jorddy N da Cruz; Sebastião G Silva; Elenilze F B Ferreira; Lúcio R de Lima; Williams J C Macêdo; José M Espejo-Román; Joaquín M Campos; Cleydson B R Santos
Journal:  Molecules       Date:  2020-09-12       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.